Hospital
University Community Hospital, INC
University Community Hospital, INC was paid $20.94M by Medicaid between Jan 2018 and Jan 2024, across 260 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.
33Billing provider infoUNIVERSITY COMMUNITY HOSPITAL, INC
TAMPA, FL 33613
TAMPA, FL 33613
33aNPI1053321919assigned 08/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.94M
24GClaims936,013
24DCodes billed260
24AFirst – last monthJan 2018 – Jan 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#14 of 163
Median peer was paid$4.77M
This provider vs. median4.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 120,219 | $1.26M | |
| 2019 | 283,930 | $6.12M | |
| 2020 | 226,915 | $5.18M | |
| 2021 | 261,895 | $7.01M | |
| 2022 | 42,984 | $1.36M | |
| 2023 | 52 | $4K | |
| 2024incomplete | 18 | $552.38 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 47,988 | 42,229 | $2.81M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.7% | 20,862 | 16,485 | $1.61M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.3% | 40,061 | 32,938 | $1.52M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.6% | 23,169 | 5,663 | $1.38M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5.3% | 9,536 | 7,758 | $1.11M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4.9% | 5,919 | 4,936 | $1.03M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 9,808 | 8,989 | $685K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 20,926 | 16,327 | $669K |
| 80053 | Comprehensive metabolic panel | 2.8% | 45,667 | 33,487 | $588K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.7% | 16,183 | 12,571 | $575K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 9,599 | 7,616 | $562K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 5,648 | 4,698 | $476K |
248 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 4,852 | $381K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 15,749 | $358K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 6,043 | $352K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 5,226 | $330K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 7,006 | $293K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 8,228 | $265K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.0% | 16,993 | $218K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 6,222 | $217K |
| 97161 | <1% | 1,637 | $200K | |
| 82947 | <1% | 15,834 | $198K | |
| 81025 | <1% | 8,378 | $194K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 14,725 | $191K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,508 | $177K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,712 | $176K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,760 | $171K |
| 0225U | <1% | 1,345 | $168K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 7,257 | $123K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,122 | $123K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 7,234 | $118K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,150 | $117K |
| 81003 | <1% | 10,556 | $115K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,109 | $114K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,646 | $112K |
| 71045 | Radiologic examination, chest; single view | <1% | 18,731 | $112K |
| 81001 | <1% | 21,086 | $105K | |
| 97162 | <1% | 1,379 | $94K | |
| G0378 | Hospital observation service, per hour | <1% | 17,225 | $93K |
| 73610 | <1% | 1,661 | $89K | |
| 86901 | <1% | 4,147 | $84K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,404 | $83K |
| 73564 | <1% | 2,113 | $79K | |
| 97163 | <1% | 1,082 | $62K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,155 | $62K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,204 | $58K |
| 86850 | <1% | 2,154 | $57K | |
| 73630 | <1% | 1,928 | $57K | |
| 73130 | <1% | 1,525 | $55K | |
| 73110 | <1% | 1,006 | $54K | |
| 73030 | <1% | 1,518 | $53K | |
| 01999 | <1% | 3,890 | $52K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,392 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 57,618 | $51K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 597 | $50K |
| 87210 | <1% | 4,636 | $49K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,165 | $48K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,192 | $48K |
| 12011 | <1% | 583 | $48K | |
| 87807 | <1% | 560 | $46K | |
| 97116 | <1% | 1,616 | $45K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 447 | $45K |
| 87070 | <1% | 4,743 | $44K | |
| 12001 | <1% | 577 | $44K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,219 | $42K |
| 96376 | <1% | 6,756 | $40K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,466 | $37K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 349 | $36K |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | <1% | 490 | $35K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 530 | $34K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,154 | $34K |
| 93971 | <1% | 1,332 | $33K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 486 | $32K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,385 | $31K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 31,362 | $30K |
| 10060 | <1% | 509 | $30K | |
| 74018 | <1% | 1,158 | $29K | |
| 84484 | <1% | 25,600 | $28K | |
| 87186 | <1% | 3,298 | $26K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,480 | $26K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 450 | $25K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 720 | $24K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 27,856 | $24K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 974 | $24K |
| 74019 | <1% | 1,039 | $24K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 552 | $23K |
| A4649 | Surgical supply; miscellaneous | <1% | 68 | $22K |
| 92587 | <1% | 521 | $22K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 950 | $22K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,788 | $21K |
| 73080 | <1% | 576 | $21K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 57 | $19K |
| 82077 | <1% | 945 | $18K | |
| 73502 | <1% | 857 | $17K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14,598 | $17K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,155 | $16K |
| 76801 | <1% | 3,014 | $16K | |
| 87430 | <1% | 918 | $15K | |
| 73140 | <1% | 212 | $15K | |
| 73090 | <1% | 387 | $14K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,013 | $14K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,994 | $14K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,594 | $13K |
| 93970 | <1% | 614 | $13K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,650 | $13K |
| 93017 | <1% | 707 | $12K | |
| 80050 | General health panel | <1% | 486 | $11K |
| 88304 | <1% | 549 | $11K | |
| 82803 | <1% | 950 | $11K | |
| 87634 | <1% | 1,168 | $11K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,071 | $11K |
| 74022 | <1% | 755 | $11K | |
| 72131 | <1% | 619 | $10K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,353 | $10K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,128 | $10K |
| 59025 | Fetal non-stress test | <1% | 188 | $10K |
| 12002 | <1% | 166 | $10K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 247 | $9K |
| 84703 | <1% | 15,420 | $9K | |
| 85610 | <1% | 7,106 | $9K | |
| 72110 | <1% | 555 | $9K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 260 | $9K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,852 | $8K |
| 85730 | <1% | 5,515 | $8K | |
| 84702 | <1% | 5,263 | $7K | |
| 70486 | <1% | 392 | $7K | |
| 73590 | <1% | 303 | $7K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 391 | $7K |
| 83880 | <1% | 5,582 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 6,864 | $7K |
| 83690 | <1% | 13,502 | $6K | |
| 87040 | <1% | 7,302 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,877 | $5K |
| 83735 | <1% | 8,837 | $5K | |
| 93976 | <1% | 362 | $5K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 157 | $5K |
| 86900 | <1% | 4,158 | $5K | |
| 80061 | Lipid panel | <1% | 2,535 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,726 | $5K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,426 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,060 | $4K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 976 | $4K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 113 | $4K |
| 83605 | <1% | 5,950 | $4K | |
| 77334 | <1% | 16 | $4K | |
| 85045 | <1% | 473 | $4K | |
| 70491 | <1% | 46 | $4K | |
| 99152 | <1% | 873 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 49 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,077 | $3K |
| 71101 | <1% | 60 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 377 | $3K |
| 85379 | <1% | 2,687 | $3K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 519 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,119 | $3K |
| 82565 | <1% | 1,395 | $3K | |
| 94760 | <1% | 1,818 | $3K | |
| C1769 | Guide wire | <1% | 983 | $2K |
| 84295 | <1% | 264 | $2K | |
| 88342 | <1% | 1,296 | $2K | |
| 36430 | <1% | 132 | $2K | |
| 86140 | <1% | 2,151 | $2K | |
| 80076 | <1% | 133 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 106 | $2K |
| 82247 | <1% | 135 | $2K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 15 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 277 | $2K |
| 84132 | <1% | 1,037 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 110 | $2K |
| 99153 | Mod sedat endo service >5yrs | <1% | 388 | $2K |
| 85027 | <1% | 3,119 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,169 | $1K |
| 90715 | <1% | 1,345 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,188 | $1K |
| 94770 | <1% | 88 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,960 | $1K |
| 82731 | <1% | 12 | $1K | |
| 73060 | <1% | 28 | $1K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 60 | $1K |
| 70360 | <1% | 28 | $1K | |
| 87077 | <1% | 2,322 | $1K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 286 | $1K |
| 85014 | <1% | 433 | $897.30 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 470 | $896.22 |
| 84145 | <1% | 1,080 | $888.16 | |
| 96367 | <1% | 613 | $868.81 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 3,205 | $855.46 |
| 82330 | <1% | 254 | $769.88 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 599 | $731.53 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 547 | $603.23 |
| 82550 | <1% | 1,590 | $568.59 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 509 | $562.49 |
| 84100 | <1% | 334 | $551.56 | |
| 86923 | <1% | 71 | $538.53 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 40 | $524.16 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,479 | $485.49 |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 102 | $479.47 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 40 | $477.00 |
| 76882 | <1% | 16 | $429.96 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,116 | $355.15 |
| 82570 | <1% | 80 | $349.50 | |
| 71250 | <1% | 38 | $341.34 | |
| 76870 | <1% | 29 | $325.92 | |
| 76775 | <1% | 26 | $319.18 | |
| 93880 | <1% | 33 | $304.18 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 600 | $304.00 |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 31 | $298.04 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 542 | $290.06 |
| 80164 | <1% | 132 | $286.67 | |
| 87641 | <1% | 189 | $278.05 | |
| 87045 | <1% | 13 | $264.87 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 879 | $258.20 |
| 95816 | <1% | 13 | $230.83 | |
| 93458 | <1% | 34 | $213.94 | |
| 87486 | <1% | 482 | $181.90 | |
| 87653 | <1% | 12 | $163.90 | |
| 94761 | <1% | 45 | $162.35 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 1,061 | $144.20 |
| 82435 | <1% | 186 | $140.09 | |
| 84520 | <1% | 127 | $140.09 | |
| 29125 | <1% | 131 | $123.18 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 1,057 | $120.63 |
| 87581 | <1% | 459 | $107.56 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 650 | $78.53 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 172 | $75.67 |
| 97167 | <1% | 61 | $61.15 | |
| 82607 | <1% | 54 | $22.85 | |
| 82140 | <1% | 129 | $19.92 | |
| 85652 | <1% | 692 | $11.70 | |
| 80185 | <1% | 14 | $7.35 | |
| 85018 | <1% | 56 | $6.39 | |
| J2704 | Injection, propofol, 10 mg | <1% | 61 | $6.36 |
| 84439 | <1% | 88 | $4.57 | |
| 84550 | <1% | 39 | $3.15 | |
| 82248 | <1% | 112 | $2.95 | |
| 84156 | <1% | 30 | $2.95 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 551 | $0.00 |
| 90686 | 0% | 169 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 1,405 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 261 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 359 | $0.00 |
| 87205 | 0% | 68 | $0.00 | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 0% | 14 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 45 | $0.00 |
| 87046 | 0% | 13 | $0.00 | |
| 72128 | 0% | 15 | $0.00 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 17 | $0.00 |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 0% | 15 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 457 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 22 | $0.00 |
| 80179 | 0% | 160 | $0.00 | |
| 36600 | 0% | 85 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 138 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 186 | $0.00 |
| 72100 | 0% | 15 | $0.00 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 0% | 15 | $0.00 |
| 80074 | 0% | 15 | $0.00 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 22 | $0.00 |
| 83540 | 0% | 16 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, TYSON (CFO)
| Provider | Location | Paid |
|---|---|---|
| University Community Hospital, INC | Tampa, FL | $14.78M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.